Local

WSU lands $7.5 million grant to study kratom’s potential for chronic pain relief

Kratom

PULLMAN, Wash. — Washington State University (WSU) is launching a major study into the herbal supplement kratom to discover whether it could help people with chronic pain.

WSU was awarded a $7.5 million grant from the National Institutes of Health to study the drug over the next five years and answer the question: Could kratom safely help millions of people worldwide who suffer from chronic pain?

“A conservative estimate of the number of people in the world who suffer from chronic pain is roughly 20%,” said Mary Paine, a professor in the Department of Pharmaceutical Sciences in WSU’s College of Pharmacy and Pharmaceutical Sciences who will lead the project. “That translates to over 1.6 billion people in the world. In the U.S., it’s about 60 million people.

“There’s a vicious cycle between chronic pain and a cascade of negative effects, including poor sleep, anxiety, reduced quality of life, and other problems,” Paine added. “That’s why it’s important to do this work — it could potentially help tens of millions of people in this country and billions of people worldwide.”

WSU researchers weigh potential benefits against safety concerns

Kratom originated in the leaves of a Southeast Asian evergreen tree and has not been approved by the Food and Drug Administration (FDA) for any medical uses. Kratom is currently sold as a pain reliever and an energy booster, though it is advertised as an alternative to opioids or a treatment for opioid withdrawal at times.

“If you take kratom at lower doses, it acts like a stimulant, but at higher doses, it acts like an opioid,” Paine said.

The study will investigate how kratom works, the risks, and its impact on the sleep and quality of life of those who suffer from chronic pain.

Several states and cities have already banned kratom, while the FDA has advised consumers against kratom products currently on the market. While there is limited research into kratom, WSU’s researchers will look into the potential positive benefits for chronic pain and negative impacts.

“I understand that the reason for banning it is to prevent harm to people, and I’m all for it not being sold to children or teenagers, not unlike alcohol and cannabis,” Paine said. “But the science has lagged behind, and some decisions are being made without having concrete, definitive scientific evidence.”

Research team plans animal studies and human sleep study

Paine has been tasked with leading the Botanical Dietary Supplements Translational Research Team, a group that will connect researchers from WSU’s colleges of Pharmacy and Pharmaceutical Sciences, Medicine, and Nursing, as well as the University of Arizona and the University of North Carolina Greensboro.

Chemists will select and authenticate a pure form of kratom, without additives and compounds often placed in products sold on the market. Scientists at Arizona and WSU will then conduct studies in mouse models, and Paine’s team in the WSU Sleep and Performance Center will ultimately carry out a sleep study on humans with chronic lower back pain.

“This is a beautiful example of an interprofessional collaboration at WSU,” Paine said.

WSU noted that results drawn from the project will generate critical data that can inform the design of future full-scale clinical efficacy trials of kratom.

0





Most Read